期刊文献+

老年科住院患者抗抑郁药物应用77例分析 被引量:5

Antidepressant treatment for elderly inpatients in geriatric ward:an analysis of 77 cases
原文传递
导出
摘要 目的探讨老年人应用抗抑郁药的安全性,为老年人合理使用抗抑郁药提供参考。方法回顾性分析2012年1月至2013年12月北京协和医院院老年示范病房77例65岁以上患者的抗抑郁药物的使用情况、起始剂量及不良反应。结果经老年医学跨学科团队会诊,77例均服用新型抗抑郁药,其中舍曲林使用率最高,对低体重指数患者更多选择米氮平治疗,伴有慢性疼痛的患者中50%使用5-羟色胺和(或)去甲肾上腺素再摄取抑制剂。70例住院后开始抗抑郁药治疗,72.8%的患者初始给药量从小剂量开始,不良反应发生率为8.6%(6/70)。结论应结合老年患者特点,以及抗抑郁药的特点、不良反应和药物之间的相互作用来选择适当的抗抑郁药物。 Objective To explore the safety of antidepressants in treatment of elderly patients and provide a basis for ration- al use of medication. Methods A retrospective chart review was conducted on 77 inpatients aged over 65 years treated with antidepressants in Geriatric Ward of our hospital. Data on medications, initial doses and adverse reactions were collected and analyzed. Results All patients were treated with the second-generation antidepressants after consultation by muhidiscipli- nary geriatric team. Sertraline was the most common medication. Most of the patients with a lower body mass index (BMI) chose mirtazapine. Half of the patients with chronic pain chose to use SNRIs. Seventy patients took antidepressants after hos- pitalization,72. 8% of them with a low initial dose. The incidence of adverse reaction was 8.6% (6/70). Conclusion Healthy problems of the elderly patients, characteristics of medications, adverse reactions and drug-drug interactions may be taken into consideration for the right choice of an antidepressant.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2014年第8期805-807,共3页 Chinese Journal of Practical Internal Medicine
基金 北京市科学技术委员会重点项目(D121100004912002)
关键词 新型抗抑郁药 老年患者 药物安全性 the second-generation antidepressants the elderly inpatient medication safety
  • 相关文献

参考文献11

  • 1解恒革,王鲁宁,于欣,王炜,杨丽娟,马腾霄,张晓红,杨丽君,许贤豪,彭丹涛,张振馨,魏镜,王荫华,贾建平,管小亭,冯峰.北京部分城乡社区老年人和痴呆患者神经精神症状的调查[J].中华流行病学杂志,2004,25(10):829-832. 被引量:48
  • 2郭敏,史冬梅.抑郁症与冠心病的关系[J].中国实用内科杂志,2010,30(5):462-464. 被引量:13
  • 3李岩.难治性功能性胃肠病的心理因素识别[J].中国实用内科杂志,2009,29(12):1091-1092. 被引量:19
  • 4Gartlehner G, Hansen RA, Morgan LC, et al. Second-Generation An- tidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review [ EB/ OL]. http://effectivehealthcare, ahrq. gov/index, cfm/search-for- guides-reviews-and-reports/? pageaction = displayproduct & pro- ductid = 862,2014 - 04 - 05/2011 - 12 - 05.
  • 5Bielski RJ, Bose A, Chang CC. A double-blind comparison of escita- lopram and paroxetine in the long-term treatment of generalized anx- iety disorder [ J ]. Ann Clin Psychiatry,2005,17 (2) :65 - 69.
  • 6Fagiolini A, Comandini A, Catena Dell'Osso M, et al. Rediscovering trazodone for the treatment of major depressive disorder [ J ]. CNS Drugs,2012,26(12) :1033 - 1049.
  • 7Civalier KA, Krahn LE, Agrwal N. Repeated episodes of neutropenia triggered by mirtazapine [ J ]. Psychosomatics ,2009,50:299 - 300.
  • 8Stahl SM, Grady MM, Moret C, et al. SNRIs: their pharmacology, clinical efficacy ,and tolerability in comparison with other classes of antidepressants [ J ]. CNS Spectr,2005, I0 (9) :732 - 747.
  • 9司天梅.米氮平改善焦虑和睡眠的机制[J].中华精神科杂志,2011,44(3):177-178. 被引量:6
  • 10Sheikh JI, Cassidy EL, Doraiswamy PM, et al. Efficacy, safety, and tolerability of sertraline in patients with late-life depression and co- morbid medical illness[ J]. J Am Geriatr Soc ,2004,52:86 - 92.

二级参考文献51

  • 1李舜伟.第一届国际睡眠障碍论坛简介[J].中华神经科杂志,2004,37(5):474-475. 被引量:32
  • 2李岩,王学清,张宁,吴建平.功能性消化不良患者抑郁及焦虑状况分析[J].中华消化杂志,2005,25(7):428-429. 被引量:49
  • 3Dykes S. Smilgin-HumphreysS bass C chronic idiopathic constipation : a psychological enquiry [ J ]. Eur J Gastroenterol Hepatol, 2001,13( 1 ) :39 -44.
  • 4Bunker SJ, Colquhoun DM, Esler MD, et al. "Stress" and coronary heart disease:psychosocial risk factors. National Heart Association of Australia position statement update [ J ]. Med JAust,2003,178 : 272 - 276.
  • 5Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study) Case-control study[ J ]. Lancet,2004,364:953 - 962.
  • 6Ruo B, Rumsfeld JS, Hlatky MA, et al. Depressive symptoms and health-related quality of life:the Heart and Soul Study [ J ]. JAMA, 2003,290:215 -221.
  • 7Swenson JR, O'Connor CM, Barton D, et al. Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome [ J ]. Am J Cardiol,2003,92 : 1271 - 1276.
  • 8van Melle JP, de Jonge P, Ormel J, et al. Relationship between left ventricular dysfunction and depression following myocardial infarction data from the MIND-IT [ J ]. Eur Heart J, 2005,22 : 2650 - 2656.
  • 9Mallik S, Krumholz HM, Lin ZQ, et al. Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery[ J]. Circulation ,2005,111:271 - 277.
  • 10Pedersen SS, Denollet J, Daemen J, et al. Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents [ J ]. J Psychosom Res, 2007,62 ( 4 ) :455 - 461.

共引文献96

同被引文献24

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部